Puma Biotechnology (PBYI) Raw Materials (2020 - 2026)
Puma Biotechnology (PBYI) posted Raw Materials of $6.0 million for Q1 2026, up 86.74% on a QoQ basis from $3.2 million in Q4 2025, and down 15.77% year-over-year from $7.1 million in Q1 2025.
Puma Biotechnology (PBYI) Raw Materials (2020 - 2026) Analysis & Trends
Puma Biotechnology's Raw Materials history runs 7 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- Quarterly Raw Materials fell 15.77% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 15.77% YoY) and the FY2025 annual result came in at $3.2 million, down 55.28% from the prior year.
- Raw Materials was $6.0 million for Q1 2026 at Puma Biotechnology, up from $3.2 million in the prior quarter.
- Across five years, Raw Materials topped out at $7.2 million in Q4 2024 and bottomed at $211000.0 in Q3 2024.
- A 5-year average of $3.7 million and a median of $3.6 million in 2025 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2024 — Raw Materials slumped 83.74% — and 2025, when it soared 1626.07%.
- Puma Biotechnology's Raw Materials stood at $1.7 million in 2022, then surged by 239.07% to $5.7 million in 2023, then climbed by 26.17% to $7.2 million in 2024, then tumbled by 55.28% to $3.2 million in 2025, then soared by 86.74% to $6.0 million in 2026.
- Business Quant data shows PBYI's Raw Materials at $6.0 million in Q1 2026, $3.2 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 6.50 Mn |
| Mar 31, 2025 | 7.12 Mn |
| Dec 31, 2024 | 7.18 Mn |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 619,000.00 |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | 5.69 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 3.81 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 4.57 Mn |
| Dec 31, 2020 | 1.43 Mn |